Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
OBJECTIVES: The overall aim of the present study was to explore the role of cognitive reserve (CR) in the conversion from mild cognitive impairment (MCI) to dementia. We used traditional and machine learning (ML) techniques to compare converter and nonconverter participants. We also discuss the predictive value of CR proxies in relation to the ML model performance.
The aim of this study was to demonstrate the usefulness of artificial neural networks in Alzheimer disease diagnosis (AD) using data of brain single photon emission computed tomography (SPECT). The results were compared with discriminant analysis. The study population consisted of 132 clinically diagnosed patients. There were 72 subjects with AD and 60 belonging to the normal control group. The ar...
BACKGROUND: In a clinical setting, an individual subject classification model rather than a group analysis would be more informative. Specifically, th...
PURPOSE: Frontotemporal dementia (FTD) is a neurodegenerative disorder associated with a poor prognosis and a substantial reduction in quality of life...
It has demonstrated that glycogen synthase kinase 3β (GSK3β) is related to Alzheimer's disease (AD). On the basis of the world largest traditional Chi...
Adequate medical images are often indispensable in contemporary deep learning-based medical imaging studies, although the acquisition of certain image...
Combining neuroimaging and clinical information for diagnosis, as for example behavioral tasks and genetics characteristics, is potentially beneficial...
The health and function of tissue rely on its vasculature network to provide reliable blood perfusion. Volumetric imaging approaches, such as multipho...
Dementia is a chronic and degenerative condition affecting millions globally. The care of patients with dementia presents an ever-continuing challenge...
Early diagnosis of Alzheimer's disease (AD) is a proceeding hot issue along with a sharp upward trend in the incidence rate. Recently, early diagnosis...
INTRODUCTION: Using machine learning techniques, we developed a brief questionnaire to aid neurologists and neuropsychologists in the screening of mil...
Measuring drug-drug similarity is important but challenging. Significant progresses have been made in drugs whose labeled training data is sufficient ...
Early and accurate mild cognitive impairment (MCI) detection within a heterogeneous, nonclinical population is needed to improve care for persons at r...
BACKGROUND: Early diagnosis of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) is essential for timely treatment. Machine learning and mu...
Accumulation of abnormal tau in neurofibrillary tangles (NFT) occurs in Alzheimer disease (AD) and a spectrum of tauopathies. These tauopathies have d...
Time-dependent data collected in studies of Alzheimer's disease usually has missing and irregularly sampled data points. For this reason time series m...
In recent years, there is a rapid increase in the population of elderly people. However, elderly people may suffer from the consequences of cognitive ...
Previous work has suggested that evoked potential analysis might allow the detection of subjects with new-onset Alzheimer's disease, which would be us...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive impairment of memory and other cognitive functions. Currently, m...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder with progressive impairment of memory and other mental functions. Magnetic reso...